Full Project 4: Time-resolved flow cytometric study of cell signaling

完整项目 4:细胞信号传导的时间分辨流式细胞术研究

基本信息

项目摘要

Specific Aims (Abstract) We will make fully operational a continuing pilot collaboration between the labs of Dr. Jessica P. Houston (NMSU) and Dr. Roger Brent (FHCRC). Our proposed work builds on complementary strengths in the two labs: instrumentation engineering and signal analysis in the Houston lab, protein engineering and genetics in the Brent lab. In particular, the work builds on "frequency domain" methods to determine fluorescence lifetimes in microscopy, and on signiflcantly more advanced developments in "frequency domain" methods for flow cytometry, for which Dr. Houston is emerging as a leader. Dysfunctions in cell signaling leading to inappropriate cell proliferation contribute to most cancers. Although much is known about cell signaling, key quesfions, including the causes and consequences of cellto- cell variation in signaling and response, remain unanswered. Here, we will use fluorescent lifefime methods to extend the power of single cell assays to quantify key events in cell signaling in yeast (the "development platform") and in mammalian cells. These measurements depend on the use of Green Fluorescent Protein (GFP) derivatives fused to the proteins that make up the different cell signaling pathways to quantify events such as recruitment of a signaling complex to the cell membrane. During the next three years, we will develop our methods, to address these quesfions and to allow wider applicafions. In particular, we will confinue to improve our instrumentafion, use it to develop better GFP derivatives and signaling reporters, and use the improved methods to understand the causes of cell-to-cell variation in a yeast signaling system. We will also use these methods to develop high-signal reporters that allow quanfificafion of cell signaling in clonal, mammalian cell lines using flow cytometry. Successful work will merit future funding. It should also increase the visibility ofthe Houston lab and help recruit new students and researchers from underrepresented ethnic minorities, at both sites, into an active area of international scientific research.
具体目标(摘要)我们将全面运作的杰西卡P.休斯顿博士(NMSU)和罗杰布伦特博士(FHCRC)的实验室之间的持续试点合作。我们提出的工作建立在两个实验室的互补优势之上:休斯顿实验室的仪器工程和信号分析,布伦特实验室的蛋白质工程和遗传学。特别是,这项工作建立在“频域”方法来确定荧光 寿命的显微镜,并在显着更先进的发展“频域”的方法, 流式细胞术,休斯顿博士正在成为领导者。 导致不适当的细胞增殖的细胞信号传导功能障碍导致大多数癌症。 虽然对细胞信号传导有很多了解,但关键问题,包括细胞信号传导的原因和后果, 细胞信号和反应的变化,仍然没有答案。在这里,我们将使用荧光寿命方法 为了扩展单细胞测定的能力以量化酵母中细胞信号传导中的关键事件(“开发 平台”)和哺乳动物细胞中。这些测量依赖于绿色荧光蛋白的使用 (GFP)与构成不同细胞信号通路的蛋白质融合的衍生物, 例如将信号复合物募集到细胞膜上。 在未来三年内,我们将发展我们的方法,以解决这些问题,并允许更广泛的 应用程序。特别是,我们将继续改进我们的仪器,用它来开发更好的GFP 衍生物和信号报告,并使用改进的方法来了解细胞间的原因, 酵母信号系统的变异。我们还将使用这些方法开发高信号报告基因, 允许使用流式细胞术定量克隆哺乳动物细胞系中的细胞信号传导。成功的工作将 值得未来的资助。它还应该增加休斯顿实验室的知名度,帮助招募新的学生, 研究人员从代表性不足的少数民族,在这两个网站,到一个活跃的国际领域, 科研

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Perea Houston其他文献

Jessica Perea Houston的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica Perea Houston', 18)}}的其他基金

G-RISE at New Mexico State University
新墨西哥州立大学 G-RISE
  • 批准号:
    10558350
  • 财政年份:
    2023
  • 资助金额:
    $ 12.59万
  • 项目类别:
Microflow time-resolved cytometry for FRET and fluorescent protein development
用于 FRET 和荧光蛋白开发的微流时间分辨细胞术
  • 批准号:
    10223368
  • 财政年份:
    2018
  • 资助金额:
    $ 12.59万
  • 项目类别:
Microflow time-resolved cytometry for FRET and fluorescent protein development
用于 FRET 和荧光蛋白开发的微流时间分辨细胞术
  • 批准号:
    10388738
  • 财政年份:
    2018
  • 资助金额:
    $ 12.59万
  • 项目类别:
Microflow time-resolved cytometry for FRET and fluorescent protein development
用于 FRET 和荧光蛋白开发的微流时间分辨细胞术
  • 批准号:
    10016369
  • 财政年份:
    2018
  • 资助金额:
    $ 12.59万
  • 项目类别:
Heterogeneous excited state sorting and analysis cytometry
异质激发态分选和分析细胞术
  • 批准号:
    7940242
  • 财政年份:
    2010
  • 资助金额:
    $ 12.59万
  • 项目类别:
NMSU RISE to the Postdoctorate Program YRS 18-22
NMSU 上升至博士后项目 YRS 18-22
  • 批准号:
    10227047
  • 财政年份:
    2000
  • 资助金额:
    $ 12.59万
  • 项目类别:
NMSU RISE to the Postdoctorate Program YRS 18-22
NMSU 上升至博士后项目 YRS 18-22
  • 批准号:
    10462572
  • 财政年份:
    2000
  • 资助金额:
    $ 12.59万
  • 项目类别:
Full Project 4: Time-resolved flow cytometric study of cell signaling
完整项目 4:细胞信号传导的时间分辨流式细胞术研究
  • 批准号:
    8926864
  • 财政年份:
  • 资助金额:
    $ 12.59万
  • 项目类别:
Full Project 4: Time-resolved flow cytometric study of cell signaling
完整项目 4:细胞信号传导的时间分辨流式细胞术研究
  • 批准号:
    8641899
  • 财政年份:
  • 资助金额:
    $ 12.59万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 12.59万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 12.59万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 12.59万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 12.59万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 12.59万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 12.59万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 12.59万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 12.59万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 12.59万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 12.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了